国务院国资委2023年启动实施央企产业焕新行动和未来产业启航行动，聚焦新一代移动通信、人工智能、生物制造、新材料等15个重点产业领域方向，推动 中央企业加快布局和发展新兴产业。 国投集团称，此次合作标志着国投集团在新质蛋白领域构建起"技术研发+产业落地"的完整链路，是发挥央企科技引领与产业带动作用的关键一步，为生物 制造这一国家战略产业注入强劲动力。 新质蛋白产业基于合成生物学技术，通过工业微生物发酵方式对农耕、畜牧等传统蛋白质获取方式进行改革升级，是生物制造新质生产力的典型代表。 国投集团投资布局生物制造领域项目118个、金额225亿元，带动投资超千亿元。 中国工程院院士陈坚表示，生物制造正处在从科技向产业转化的爆发期，产业规模将从2025年的1.6万亿发展到2030年的3万亿元。 中国科学院天津工业生物技术研究所研究员李德茂谈到，新质蛋白是近年来在保障粮食安全和可持续发展背景下兴起的一个重要概念，旨在减少对传统养殖 业的依赖，是全球生物安全的战略必争之地。随着我国技术的快速发展，国际上对我国构成的专利和产品的垄断正在改观。 "十五五"规划建议明确提出要前瞻布局未来产业，推动生物制造等成为新的经济增长点。 ...

Core Insights - Switzerland has ranked first in the global innovation index for 14 consecutive years since 2011, making it a significant source of innovation and the first strategic partner of China in innovation development and technology finance [2] - Planetary, a Swiss food technology company founded in 2021, focuses on developing mycelium protein fermentation technology to support industrial-scale biomass fermentation and provide mycelium protein raw materials [3][9] Company Overview - Planetary was co-founded by Marison Ian, who has over 40 years of experience in industrial fermentation, and David Brandes, who is also a co-founder of Peace of Meat [3] - The company offers upstream and downstream manufacturing services in the biomass fermentation and precision fermentation sectors, addressing the capacity bottleneck in the fermentation industry [7] Industry Context - Animal-based meat and dairy products account for over 20% of global greenhouse gas emissions and consume more than 30% of water resources and over 70% of agricultural land [5] - Fermentation-derived proteins are a more sustainable alternative, requiring less water and land, and producing lower greenhouse gas emissions [5] Technology and Production - Planetary utilizes proprietary BioBlocks™ fermentation technology and an AI platform for high-throughput screening and real-time monitoring of fungal strains and fermentation conditions [8] - The company’s mycelium protein has a PDCAAS (Protein Digestibility-Corrected Amino Acid Score) of 0.996, with a carbon dioxide equivalent of only 0.79 kg per kilogram of product, significantly lower than similar products [8] Market Presence - Planetary's first industrial-scale mycelium protein production facility is located in Alberg, Switzerland, which is currently the only industrial mycelium protein fermentation base in continental Europe [8] - In July 2025, Aldi Switzerland began selling new vegetarian chicken strips made from Planetary's fermented mycelium protein across 242 stores in Switzerland [9] Funding and Future Plans - In April 2022, Planetary completed a seed round financing of 7.5 million Swiss francs, led by Astanor Ventures, to initiate the construction of its flagship production facility in Switzerland [9] - The company plans to build and operate a global network of biomass fermentation capacity to overcome industry capacity bottlenecks [9]

Core Insights - Planetary is a Swiss food technology company founded in 2021, focusing on mycelium protein fermentation technology to support industrial-scale biomass fermentation and provide mycelium protein raw materials [2][5][7] Company Overview - Planetary was co-founded by Marison Ian and David Brandes, with Ian serving as Chief Scientific Officer and Brandes as CEO [2] - The company aims to address the bottleneck in biomass fermentation by providing upstream and downstream manufacturing services and selling mycelium protein as a B2B raw material for meat and dairy alternatives [7][9] Industry Context - Animal-derived meat and dairy products contribute over 20% of global greenhouse gas emissions and consume more than 30% of water resources and over 70% of agricultural land [5] - Fermentation-derived proteins are a more sustainable alternative, requiring less water and land while producing lower greenhouse gas emissions [5] Product and Technology - Mycelium protein is a whole food ingredient derived from the root structure of filamentous fungi, rich in protein, fiber, and fat, and requires fewer flavoring agents [7][8] - Planetary utilizes proprietary BioBlocks™ fermentation technology and an AI platform for high-throughput screening and real-time monitoring to produce cost-effective mycelium protein [8] - The company’s mycelium protein has a PDCAAS (Protein Digestibility-Corrected Amino Acid Score) of 0.996, with a carbon dioxide equivalent emission of only 0.79 kg per kilogram of product [8] Market Presence - Planetary's first industrial-scale mycelium protein production facility is located in Alberg, Switzerland, which is currently the only industrial mycelium protein fermentation site in continental Europe [8] - The company has begun supplying high-quality, animal-free mycelium protein to retailers, with Aldi Switzerland selling new vegetarian chicken strips made from Planetary's fermentation [9] Funding and Future Plans - In April 2022, Planetary completed a seed funding round of 7.5 million Swiss francs led by Astanor Ventures, with additional investments from XAnge, Blue Horizon, and Nucleus Capital [9] - The company plans to build and operate a global network of biomass fermentation capacities to overcome industry capacity bottlenecks [9] Recognition - Planetary is listed in the 2025 TOP100 Swiss Startups, which highlights innovative and market-potential companies in Switzerland [11]

Core Insights - The company has established a pilot production line for mycelium protein and completed the research on the pilot production process, indicating a foundation for industrialization and promotion [1] - A new production facility is currently under construction, which is expected to enhance production capacity [1] - According to the feasibility study report, once the project is fully operational, it is projected to generate an annual revenue of 1.3 billion yuan [1]

Core Insights - The Chinese biological manufacturing industry is experiencing robust growth, with a total scale nearing 1 trillion yuan and fermentation capacity accounting for over 70% of the global market [1][2] - Microbial protein represents a disruptive innovation in the food supply system, offering a more efficient and environmentally friendly alternative to traditional agriculture and livestock farming [3][4] Industry Overview - The biological manufacturing sector is characterized by the use of industrial biotechnology, leveraging microorganisms, cells, and enzymes for product production [2] - The industry is currently in a "blue ocean" phase, with less than 1% of microbial species on Earth having been discovered, indicating significant potential for resource exploration and development [2] Technological Advancements - New strains of fungi developed through large-scale industrial fermentation can yield protein content exceeding 50%, comparable to animal-derived meat in terms of nutrition and taste [1] - Synthetic biology techniques are significantly reducing the costs of pharmaceuticals, such as the production of bear bile acid substitutes, which are now much more affordable and environmentally sustainable [4][5] Environmental Impact - Microbial protein production can replace the protein generated from traditional sources like soybeans and livestock, leading to a reduction of over 90% in land, water usage, and carbon emissions [3] - The production facility for fungal protein can replace the protein output of 10,000 cattle or 24 million chickens, showcasing its environmental advantages [3] Policy and Investment - The growth of the biological manufacturing industry is supported by targeted industrial policies and patient capital, which are crucial for scaling production and fostering innovation [5][6] - The Ministry of Industry and Information Technology (MIIT) is actively promoting the application of artificial intelligence in biological manufacturing and facilitating the transition from research to industrial application [7] Collaboration and Innovation - Successful innovation in the biological manufacturing sector requires collaboration between academia and industry, with a focus on integrating research outcomes into practical applications [6][7] - The establishment of innovation centers aims to bridge the gap between basic research and industrial implementation, facilitating the transfer of scientific achievements into market-ready products [7]

【SynBioCon】 获 悉， 4月28日，主题为"技术造物 创引未来"的天津港保税区生物制造产业新闻发 布会举行。会上，天津港保税区发布了 《天津港保税区推动生物制造产业高质量发展行动方案》 （以 下简称《行动方案》）和 《天津港保税区关于支持生物制造产业高质量发展的若干政策》 （以下简 称"生物制造十条"）。 近些年，生物制造作为全新的"造物"技术，成为全球竞相布局的科技战略高地。今年政府工作报告中 提到，因地制宜发展新质生产力，培育生物制造、量子科技、具身智能、6G等未来产业。我市去年已 印发《天津市加快合成生物创新策源推动生物制造产业高质量发展实施方案》，天津港保税区按照全市 工作部署正全力打造生物制造先导区。此次发布会展现了天津港保税区生物制造产业在创新策源、成果 产业化、空间布局、人才支撑、标志性项目等方面的先发优势及推动生物制造创新成果产业化应用实 践，促进新产业、新模式、新动能加快 落地。 01 政策上新 全力打造百亿级产业集群 记者从会上获悉，《行动方案》以推动生物制造创新成果产业化应用实践为主线，因地制宜构建符合新 质生产力发展的新型生产关系，重点聚焦创新策源地、孵化转化高地和创新生态三 ...